ReqVise

Resource Over-allocation Alert
RK
Rajesh Kumar
Project Manager PMO Department [email protected] +91 98765 43210
Total Allocation
120%
Over By
20%
Projects
2
Allocation Overview
100%
Cipla R&D Lab: 100% Serum BSL-3: 20%
Total: 120%

Allocation Breakdown

Project Role Duration Allocation Reducible Notes
PRJ-2025-001
Cipla R&D Lab Setup
Project Manager Jan 2025 – Jun 2025 100% Cannot Reduce Critical project — sole PM assigned. Customer-facing role.
PRJ-2025-005
Serum Institute BSL-3 Lab
Advisory PM Mar 2025 – Dec 2025 20% Reducible Advisory role only. Can be reassigned to deputy PM.

Conflict Timeline

Week-by-week allocation view (Mar – Dec 2025)
Project
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Cipla R&D Lab
100%
Serum BSL-3
20%
Total Allocation
100%
100%
120%
120%
120%
120%
20%
20%
20%
20%
20%
20%
Overlap Period: March 2025 – June 2025 (4 months). Rajesh Kumar is allocated at 120% during this period, exceeding the 100% capacity threshold by 20%.

Resolution Options

Select a resolution to apply
Option A — Recommended
Reduce Serum BSL-3 allocation to 10%
Reassign primary advisory responsibilities to Ananya Patel as Deputy PM. Rajesh retains oversight at 10% allocation for escalations only.
Cost Impact Minimal
Schedule Impact None
Risk Level Low
New Total 110%
Option B
Delay Serum BSL-3 start to July 2025
Postpone Serum BSL-3 project kick-off until Cipla R&D Lab completes in June 2025. Rajesh becomes fully available for Serum project from July.
Cost Impact Moderate
Schedule Impact +4 months
Risk Level Medium
New Total 100%
Option C
Bring in external PM for Serum BSL-3
Hire a contract Project Manager for the Serum BSL-3 project. Rajesh provides initial 2-week knowledge transfer and then disengages.
Cost Impact +₹3,50,000/mo
Schedule Impact +2 weeks
Risk Level Medium
New Total 100%
Option D
Accept over-allocation (with manager approval)
Maintain current allocation at 120%. Requires formal approval from VP Operations. Monitor for burnout risk and adjust if performance degrades.
Cost Impact None
Schedule Impact None
Risk Level High
New Total 120%